Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - brinzolamide, quantity: 10 mg/ml - eye drops - excipient ingredients: benzalkonium chloride; disodium edetate; sodium chloride; tyloxapol; mannitol; carbomer 974p; hydrochloric acid; sodium hydroxide; purified water - brinzoquin eye drops 1.0% are indicated to decrease intraocular pressue in: ocular hypertension & open-angle glaucoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - diclofenac sodium, quantity: 1 mg/ml - eye drops, solution - excipient ingredients: benzalkonium chloride; disodium edetate; hydroxypropylbetadex; hydrochloric acid; propylene glycol; trometamol; tyloxapol; water for injections - post-operative inflammation in cataract surgery and other surgical interventions.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - brinzolamide, quantity: 10 mg/ml - eye drops - excipient ingredients: benzalkonium chloride; disodium edetate; sodium chloride; tyloxapol; mannitol; carbomer 974p; hydrochloric acid; sodium hydroxide; purified water - azopt 1.0% eye drops are indicated to decrease intraocular pressure in : ocular hypertension; open-angle glaucoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - betaxolol hydrochloride, quantity: 5.6 mg/ml (equivalent: betaxolol, qty 5 mg/ml) - eye drops, solution - excipient ingredients: purified water; disodium edetate; sodium chloride; hydrochloric acid; benzalkonium chloride; sodium hydroxide - indications as at 23 march 1999: betoquin eye drops 0.5% have been shown to be effective in lowering intraocular pressure and are indicated in the treatment of ocular hypertension or chronic open angular glaucoma. betoquin eye drops 0.5% may be used alone or in combination with other iop-lowering medication.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

mundipharma pty ltd - dorzolamide hydrochloride, quantity: 22.26 mg/ml (equivalent: dorzolamide, qty 20 mg/ml) - eye drops, solution - excipient ingredients: mannitol; sodium citrate dihydrate; benzalkonium chloride; hyetellose; water for injections; sodium hydroxide - trusopt eye drops are indicated in the treatment of elevated intraocular pressure in patients with ocular hypertension or open- angle glaucoma.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

novartis pharmaceuticals australia pty ltd - lodoxamide trometamol, quantity: 1.78 mg/ml (equivalent: lodoxamide, qty 1 mg/ml) - eye drops, solution - excipient ingredients: citric acid monohydrate; hydrochloric acid; mannitol; disodium edetate; tyloxapol; purified water; sodium citrate dihydrate; benzalkonium chloride; sodium hydroxide; hypromellose - seasonal allergic conjunctivitis and vernal keratoconjunctivitis in adults and children four years of age and older. prophylactic use of lomide eye drops may help in the management of seasonal allergic conjunctivitis and assist in reducing the allergic symptoms.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

arrotex pharmaceuticals pty ltd - timolol maleate, quantity: 6.83 mg/ml (equivalent: timolol, qty 5 mg/ml); latanoprost, quantity: 0.05 mg/ml - eye drops, solution - excipient ingredients: purified water; benzalkonium chloride; dibasic sodium phosphate dodecahydrate; sodium hydroxide; monobasic sodium phosphate dihydrate; hydrochloric acid; sodium chloride - reduction of elevated intraocular pressure in patients with open-angle glaucoma and ocular hypertension who are insufficiently responsive to beta-blockers, prostaglandins or other intraocular pressure lowering medications. latanoprost/timolol (50 microgram/ml/5 mg/ml) eye drops should not be used to initiate therapy.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

alcon laboratories australia pty ltd - proxymetacaine hydrochloride, quantity: 5 mg/ml - eye drops, solution - excipient ingredients: glycerol; benzalkonium chloride; hydrochloric acid; purified water; sodium hydroxide - indications as at 13 jan 2005 : alcaine eye drops are indicated for procedures in which a rapid and short-acting topical ophthalmic anaesthetic is indicated such as in cataract surgery and suture removal from the cornea, and in tonometry, gonioscopy, removal of corneal foreign bodies, conjunctival scraping for diagnostic purposes, and other short corneal and conjunctival procedures.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharma pty ltd - atropine sulfate monohydrate, quantity: 9.9737 mg/ml - eye drops, solution - excipient ingredients: boric acid; disodium edetate; benzalkonium chloride; hypromellose; water for injections - indications as at 06 august 1999: atropt eye drops are indicated where it is necessary to dilate the pupil and paralyse accomodation.

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sun pharma anz pty ltd - ciclosporin, quantity: 900 microgram/ml - eye drops - excipient ingredients: peg-40 hydrogenated castor oil; octoxinol 40; monobasic sodium phosphate dihydrate; dibasic sodium phosphate; sodium chloride; povidone; water for injections; hydrochloric acid; sodium hydroxide - cequa is indicated to increase tear production in patients with moderate to severe keratoconjunctivitis sicca (dry eye) where prior use of artificial tears has not been sufficient.